T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Lindblad Expeditions
LIND
$2.25B
| $38.3M | 0.01% |
3,599,940
+1,799,970
| +100% | +$17.8M |
|
927
Compass Diversified
CODI
$939M
| $38.2M | 0.01% |
2,233,212
-94,566
| -4% | -$1.57M |
|
|
FRED
928
DELISTED
Fred's Inc
FRED
| $37.6M | 0.01% |
2,198,854
-5,470
| -0.2% | -$97.9K |
|
929
Jacobs Solutions
J
$16.8B
| $37.4M | 0.01% |
1,001,530
-394,003
| -28% | -$13.8M |
|
930
Zimmer Biomet
ZBH
$18.8B
| $36.9M | 0.01% |
323,127
+19,982
| +7% | +$2.28M |
|
|
CCI.PRA
931
DELISTED
Crown Castle International Corp.
CCI.PRA
| $36.8M | 0.01% |
352,271
-9,281
| -3% | -$987K |
|
|
RAI
932
DELISTED
Reynolds American Inc
RAI
| $36.7M | 0.01% |
1,065,576
+45,420
| +4% | +$1.59M |
|
933
Matsons
MATX
$6.43B
| $36.6M | 0.01% |
867,641
-51,710
| -6% | -$1.96M |
|
934
Preferred Bank
PFBC
$1.27B
| $36.5M | 0.01% |
1,329,980
+17,772
| +1% | +$482K |
|
|
CEB
935
DELISTED
CEB Inc.
CEB
| $36.5M | 0.01% |
457,300
-1,275
| -0.3% | -$96K |
|
|
NGD
936
DELISTED
New Gold Inc
NGD
| $36.4M | 0.01% |
10,839,670
+10,822,470
| +62,921% | +$42.6M |
|
|
EBSB
937
DELISTED
Meridian Bancorp, Inc.
EBSB
| $36.3M | 0.01% |
2,757,342
+1,495,557
| +119% | +$18.2M |
|
|
CTRL
938
DELISTED
Control4 Corporation
CTRL
| $36.3M | 0.01% |
3,029,542
+34,880
| +1% | +$476K |
|
939
BJ's Restaurants
BJRI
$1.43B
| $36.3M | 0.01% |
718,883
-235,170
| -25% | -$11.6M |
|
|
HAYN
940
DELISTED
Haynes International, Inc.
HAYN
| $36.2M | 0.01% |
812,148
+500
| +0.1% | +$20.9K |
|
|
SMRT
941
DELISTED
Stein Mart Inc
SMRT
| $36.2M | 0.01% |
2,905,899
-1,380,181
| -32% | -$19.5M |
|
942
Paychex
PAYX
$43.4B
| $36.2M | 0.01% |
728,621
+59,905
| +9% | +$2.91M |
|
943
Public Service Enterprise Group
PEG
$37.8B
| $36M | 0.01% |
859,436
+36,190
| +4% | +$1.51M |
|
944
Novartis
NVS
$289B
| $36M | 0.01% |
407,516
+6,528
| +2% | +$579K |
|
|
ADXS
945
DELISTED
Advaxis Inc
ADXS
| $36M | 0.01% |
166,214
+85,029
| +105% | +$13.1M |
|
|
BV
946
DELISTED
Bazaarvoice, Inc.
BV
| $35.9M | 0.01% |
6,360,848
-3,541,368
| -36% | -$27.2M |
|
947
Hershey
HSY
$37.3B
| $35.8M | 0.01% |
355,106
-2,015
| -0.6% | -$210K |
|
948
Edison International
EIX
$26.8B
| $35.8M | 0.01% |
572,273
+29,710
| +5% | +$1.94M |
|
949
Community Health Systems
CYH
$417M
| $35.4M | 0.01% |
819,642
+1,758
| +0.2% | +$72.8K |
|
950
PennyMac Financial
PFSI
$4.13B
| $35.2M | 0.01% |
2,074,430
-36,425
| -2% | -$647K |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.